Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer

Teemu T. Junttila, Guangmin Li, Kathryn L. Parsons, Gail D. Lewis Phillips, Mark X. Sliwkowski

Breast Cancer Research and Treatment

August 20, 2010

10.1007/s10549-010-1090-x

Cited by 531

Abstract

Related Papers

The Hallmarks of Cancer

Douglas Hanahan, Robert A. Weinberg|Cell|2000|28.5k

Molecular portraits of human breast tumours

Charles M. Perou, Thérese Sørlie, Michael B. Eisen et al.|Nature|2000|16.3k

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

Peter J. Munson, David Rodbard|Analytical Biochemistry|1980|8.5k

Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer

Dennis J. Slamon, William Godolphin, Lovell A. Jones et al.|Science|1989|6.8k

Humanization of an anti-p185HER2 antibody for human cancer therapy.

Paul Carter, Leonard G. Presta, C Gorman et al.|Proceedings of the National Academy of Sciences|1992|1.9k